When it comes to patient-reported outcome measures, getting better or worse is really the bottom line for a disease that sadly tends to get worse over time.
dQ&A is announcing upcoming data releases for our flagship products: Prescriber Perspectives (Europe) and Patient Voice (Europe).
Given that T1D patients share many of the same comorbidities as T2D patients, doctors have been prescribing them to T1D patients ‘off label’.
